Not Yet Recruiting
Phase II Study of QL1706 Combined With Paclitaxel and Bevacizumab for Second-Line Immune Rechallenge in Gastric Cancer
NCT07045805
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer (GC), +6 more
- Locations
-
Not specified